294 related articles for article (PubMed ID: 23921083)
1. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
[TBL] [Abstract][Full Text] [Related]
2. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
4. Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.
Zhang Z; Liao H; Chen X; Zheng Y; Liu Y; Tao X; Gu C; Dong L; Duan T; Yang Y; Liu X; Yu Y; Feng Y
Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):69-74. PubMed ID: 21074309
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
Liu X; Wang A; Gao H; Yuan Z; Jiao Y
Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
Jiang L; Luo RY; Yang J; Cheng YX
Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
[TBL] [Abstract][Full Text] [Related]
7. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
8. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
[TBL] [Abstract][Full Text] [Related]
9. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
[TBL] [Abstract][Full Text] [Related]
10. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Li J; Liu P; Mao H; Wanga A; Zhang X
Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H
Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
[TBL] [Abstract][Full Text] [Related]
13. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
Tang J; Cao L; Yi H; Tang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
[TBL] [Abstract][Full Text] [Related]
15. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
16. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
Yuan-Jing F; Nan-Shan H; Lian X
Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
[TBL] [Abstract][Full Text] [Related]
17. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
Song J; Cao L; Li Y
Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
[TBL] [Abstract][Full Text] [Related]
18. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
Huang Q; Zeng Y; Lin H; Zhang H; Yang D
Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
[TBL] [Abstract][Full Text] [Related]
19. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
20. Effect of shRNA targeting survivin on ovarian cancer.
Xing J; Jia CR; Wang Y; Guo J; Cai Y
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1221-9. PubMed ID: 22426961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]